<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>PeritonEasy | Market & Strategy</title>
  <style>
    :root{--primary:#0a7e9e;--primary-dark:#055468;--light-bg:#f9f9f9;--text:#222;}
    *{margin:0;padding:0;box-sizing:border-box;}
    body{font-family:'Segoe UI',Roboto,Arial,sans-serif;background:var(--light-bg);color:var(--text);line-height:1.6;}
    header{background:var(--primary);color:white;padding:3rem 1rem;text-align:center;}
    nav{background:white;display:flex;justify-content:center;gap:2rem;padding:1rem;box-shadow:0 2px 6px rgba(0,0,0,0.1);position:sticky;top:0;}
    nav a{color:var(--primary);font-weight:bold;text-decoration:none;transition:color 0.2s ease;}
    nav a:hover{color:var(--primary-dark);}
    .container{max-width:1000px;margin:2rem auto;padding:0 1rem;}
    .card{background:white;border-radius:12px;padding:2rem;margin-bottom:2rem;box-shadow:0 2px 8px rgba(0,0,0,0.08);}
    .card h2{color:var(--primary);margin-bottom:1rem;}
    img{max-width:100%;border-radius:12px;margin-top:1rem;}
    footer{background:var(--primary-dark);color:white;text-align:center;padding:1.5rem;margin-top:3rem;}
  </style>
</head>
<body>
  <header><h1>Market & Strategy</h1></header>
  <nav>
    <a href="index.html">Overview</a>
    <a href="home.html">Home</a>
    <a href="development.html">Development</a>
    <a href="market.html">Market & Strategy</a>
    <a href="references.html">References</a>
    <a href="team.html">Team</a>
  </nav>
  <div class="container">
    <div class="card" id="impact">
      <h2>Impact</h2>
    <p>
      The dialysis market is projected to reach $209.75B globally by 2034. PeritonEasy reduces
      treatment-related complications, improves patient quality of life, and aligns with CMS incentives
      for home dialysis. By filling the gap in customizable dialysate, it offers a scalable and impactful
      innovation in kidney care.
    </p>
    </div>
    <div class="card" id="manufacturing">
      <h2>Manufacturing</h2>
    <p>
      PeritonEasy was designed with manufacturing feasibility in mind to keep per-unit costs low at scale. Early estimates
      indicate a competitive per-unit cost when produced at volume; detailed cost breakdowns and supplier lists are
      maintained internally and available to collaborators under NDA.
    </p>
    </div>
    <div class="card" id="regulatory">
      <h2>Regulatory Pathway</h2>
    <p>
      PeritonEasy is expected to be classified as a Class II device under FDA guidelines, following the 510(k) pathway.
      Predicate devices include Baxter’s HomeChoice Pro Automated PD System. The device will comply with relevant
      standards (21 CFR 876.5630, ISO 10993, IEC 60601-1, ISO 11607, FDA SaMD guidance, ISO 14971).
      Sterility and electronic safeguards will be incorporated into manufacturing. Intellectual property includes modular
      refillable cartridges, physician-adjustable algorithms, and ultrasonic sensor validation loops specific to PD.
    </p>
    </div>
    <div class="card" id="patents">
      <h2>Patents</h2>
    <p>
      The team has reviewed related technologies and is developing an IP strategy focused on protecting the novel
      aspects of PeritonEasy (cartridge modularity, clinician-guided formulation workflows, and validation loops).
      Specific patent filings and detailed prior-art analysis are being managed with advisors and are not published here.
    </p>
    </div>
    <div class="card" id="reimbursement">
      <h2>Reimbursement</h2>
    <p>
      CMS incentivizes home dialysis via the Advancing American Kidney Health initiative. ESRD patients qualify for Medicare regardless of age.
      PeritonEasy integrates seamlessly into current workflows and is expected to qualify under existing billing for PD supplies and services.
      Aligns with CMS cost-containment and value-based care models, supporting broad reimbursement through Medicare and Medicaid.
    </p>
      <img src="images/market-placeholder.jpg" alt="Market growth chart placeholder" />
    </div>
  </div>
  <footer><p>© 2025 PeritonEasy Team | Georgia Institute of Technology</p></footer>
</body>
</html>
